Mangoceuticals (MGRX) Income from Non-Controlling Interests (2023 - 2026)
Mangoceuticals' (MGRX) quarterly Income from Non-Controlling Interests came in at -$1533.0 in Q1 2026, down 1464.29% year-on-year from $112.37 in Q1 2025, and down 878.17% quarter-over-quarter from $197.0 in Q4 2025.
Mangoceuticals (MGRX) Income from Non-Controlling Interests (2023 - 2026) Analysis & Trends
Mangoceuticals has disclosed Income from Non-Controlling Interests across 4 years of filings, most recently posting -$1533.0 for Q1 2026.
- Income from Non-Controlling Interests for Q1 2026 came in at -$1533.0, down 1464.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1896.0 (down 65.88% YoY), and the FY2025 annual result was -$461.0, up 57.35% from the prior year.
- Income from Non-Controlling Interests came in at -$1533.0 for Q1 2026 at Mangoceuticals, down from $197.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $197.0 in Q4 2025 to a low of -$1.8 million in Q3 2023.
- The 4-year median for Income from Non-Controlling Interests is -$292.0 (2024), against an average of -$180253.5.
- Across the five-year window, Income from Non-Controlling Interests soared 180.74% in 2025 and slumped 1464.29% in 2026, its largest moves.
- Mangoceuticals' Income from Non-Controlling Interests stood at -$1.8 million in 2023, then jumped by 99.99% to -$244.0 in 2024, then surged by 180.74% to $197.0 in 2025, then sank by 878.17% to -$1533.0 in 2026.
- The last three Income from Non-Controlling Interests figures came in at -$1533.0 (Q1 2026), $197.0 (Q4 2025), and -$558.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | -157,000.00 |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | - |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | - |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | - |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 646,000.00 |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | - |
| 10 | Mangoceuticals | 5.25 Mn | 5.06 Mn | 29,001.00 | -1,533.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,533.00 |
| Dec 31, 2025 | 197.00 |
| Sep 30, 2025 | -558.00 |
| Jun 30, 2025 | -2.00 |
| Mar 31, 2025 | -98.00 |
| Dec 31, 2024 | -244.00 |
| Sep 30, 2024 | -461.00 |
| Jun 30, 2024 | -340.00 |
| Mar 31, 2024 | -36.00 |
| Sep 30, 2023 | -1.80 Mn |